Role of CYB5R3 in erythropoiesis
About This Grant
Grant title: Role of CYB5R3 in erythropoiesis Funding mechanism: NIH/NHLBI-F32 PROJECT SUMMARY/ABSTRACT Cytochrome b5 reductase 3 (CYB5R3) plays a critical role in regulating redox signaling in both physiological and pathological contexts. Key biological substrates of CYB5R3 include hemoproteins such as hemoglobin, myoglobin, and soluble guanylate cyclase (sGC), as well as vitamin E and coenzyme Q. Our recent findings demonstrate that the CYB5R3 T117S variant, which results in approximately 50% loss of reductase activity, serves as a modifier of hydroxyurea-induced fetal hemoglobin (HbF) production—a widely used therapeutic approach for managing anemia in sickle cell disease (SCD). Using CYB5R3 knockout CD34+ hematopoietic stem cells (HSC)s, we found depleted baseline hemoglobin and impaired hydroxyurea- induced HbF production and erythroid maturation. In CYB5R3-deleted human erythroleukemic K562 cells, we similarly found depleted baseline hemoglobin, but in the presence of heme deficiency. The role of CYB5R3 in erythropoiesis remains unexplored despite. Based on our preliminary and published data, we hypothesize that CYB5R3 plays a previously unrecognized role in erythropoiesis by regulating heme biosynthesis. This hypothesis will be tested using two specific aims: Aim 1 will investigate the impact of CYB5R3 depletion on hemoglobin synthesis and erythropoiesis using human K562 cells. Aim 2 will employ a novel mouse model with hematopoietic compartment-specific deletion of CYB5R3 to assess its effects on erythropoiesis in vivo, both under baseline conditions and following hypoxic conditions. Successful completion of this study will provide novel insights into the significance of CYB5R3 in erythropoiesis, with potential applications in drug development, regenerative medicine, and the improved management of genetic anemias. Moreover, this research—plan combined with mentored training under Drs. Straub and Wood, interdisciplinary collaborations, and a structured career development plan within the outstanding training environment at the University of Pittsburgh School of Medicine—will equip the applicant with the expertise necessary to achieve a long-term career in biomedical research.
Grant Summary
Role of CYB5R3 in erythropoiesis is a NHLBI - National Heart Lung and Blood Institute grant providing up to $79K for university, nonprofit, healthcare org. Applications are due 2028-07-31 (open). Check eligibility and apply with FindGrants.
Not quite the right fit?
Search 9,000+ open grants, or get matches ranked for your organization — free.
Focus Areas
Eligibility
How to Apply
Up to $79K
2028-07-31
- 1Confirm your organization is eligible for Role of CYB5R3 in erythropoiesis from NHLBI - National Heart Lung and Blood Institute, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NHLBI - National Heart Lung and Blood Institute before the deadline.
Don't want to draft it yourself?
We'll draft the complete application against NHLBI - National Heart Lung and Blood Institute's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
Role of CYB5R3 in erythropoiesis: Frequently Asked Questions
Who is eligible for the Role of CYB5R3 in erythropoiesis?
Role of CYB5R3 in erythropoiesis is offered by NHLBI - National Heart Lung and Blood Institute and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the Role of CYB5R3 in erythropoiesis provide?
Role of CYB5R3 in erythropoiesis provides up to $79K per award from NHLBI - National Heart Lung and Blood Institute. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the Role of CYB5R3 in erythropoiesis deadline?
Applications for Role of CYB5R3 in erythropoiesis are due 2028-07-31 (open). Because deadlines can change, verify the date with the funder, NHLBI - National Heart Lung and Blood Institute, and give yourself enough time to prepare a complete, competitive application before the close date.
How do you apply for the Role of CYB5R3 in erythropoiesis?
To apply for Role of CYB5R3 in erythropoiesis, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NHLBI - National Heart Lung and Blood Institute.